Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/107254
Title: A temperature-cured dissolvable gelatin microsphere-based cell carrier for chondrocyte delivery in a hydrogel scaffolding system
Authors: Leong, Wenyan
Lau, Ting Ting
Wang, Dong-An
Issue Date: 2012
Source: Leong, W., Lau, T. T., & Wang, D.-A. (2013). A temperature-cured dissolvable gelatin microsphere-based cell carrier for chondrocyte delivery in a hydrogel scaffolding system. Acta Biomaterialia, 9(5), 6459-6467.
Series/Report no.: Acta biomaterialia
Abstract: In this study, a novel therapeutic cell delivery methodology in the form of hydrogel encapsulating cell-laden microspheres was developed and investigated. As a model cell for cartilage tissue engineering, chondrocytes were successfully encapsulated in gelatin-based microspheres (mostly of diameter 50–100 μm, centred at 75–100 μm) with high cell viability during the formation of microspheres via a water-in-oil single emulsion process under a low temperature without any chemical treatment. These cell-laden microspheres were then encapsulated in alginate-based hydrogel constructs. By elevating the temperature to 37 °C, the cell-laden microspheres were completely dissolved within 2 days, resulting in the same number of same-sized spherical cavities in hydrogel bulk, along with which the encapsulated cells were released from the microspheres and suspended inside the cavities to be cultivated for further development. In this cell delivery system, the microspheres played a dual role as both removable cell vehicles and porogens for creation of the intra-hydrogel cavities, in which the delivered cells were provided with both free living spaces and a better permeable environment. This temperature-cured dissolvable gelatin microsphere-based cell carrier (tDGMC) associating with cell-laden hydrogel scaffold was attempted and evaluated through WST-1, quantitative polymerase chain reaction, biochemical assays and various immunohistochemistry and histology stains. The results indicate that tDGMC technology can facilitate the delivery of chondrocytes, as a non-anchorage-dependent therapeutic cell, with significantly greater efficiency.
URI: https://hdl.handle.net/10356/107254
http://hdl.handle.net/10220/17847
ISSN: 1742-7061
DOI: 10.1016/j.actbio.2012.10.047
Rights: © 2012 Acta Materialia Inc.
Fulltext Permission: none
Fulltext Availability: No Fulltext
Appears in Collections:SCBE Journal Articles

SCOPUSTM   
Citations

40
Updated on Jul 24, 2020

PublonsTM
Citations

45
Updated on Jan 11, 2021

Page view(s)

401
Updated on Jan 15, 2021

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.